(Q36482125)
Statements
Developing chemokine mutants with improved proteoglycan affinity and knocked-out GPCR activity as anti-inflammatory recombinant drugs (English)
Potzinger H
Geretti E
Brandner B
Wabitsch V
Rek A
scientific article